The ICCVAM Authorization Act of 2000 directed ICCVAM to prepare a progress report on its first anniversary and biennially thereafter. This 2022-2023 biennial report summarizes progress by ICCVAM agencies toward encouraging the development, utilization, and building of confidence in new methods as set forth in the 2018 ICCVAM report, A Strategic Roadmap for Establishing New Approaches to Evaluate the Safety of Chemicals and Medical Products in the United States.
https://ntp.niehs.nih.gov/go/2023iccvamreport